Jeffrey W. Moses, MD
Overview
Areas of Expertise / Conditions Treated
Academic Appointments
- Professor of Medicine at NewYork-Presbyterian/Columbia University Medical Center
Administrative Titles
- Director, Interventional Cardiovascular Therapeutics
An internationally recognized interventional cardiologist, Dr. Jeffrey W. Moses Professor of Medicine at Columbia University Medical Center has performed more than 18,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. Dr. Moses is an Associate Director of the Transcatheter Cardiovascular Therapeutics (TCT) conference, the world’s largest interventional cardiology conference. He serves on the Board of the Cardiovascular Research Foundation in New York City; and he has made important contributions in the areas of clinical research and educational activities in interventional vascular therapy. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures. Dr. Moses, who previously held a professorship in Clinical Medicine at New York University School of Medicine, also served in various positions at The New York Hospital (now New York-Presbyterian/Weill Cornell) in New York, where he became Associate Director of the Adult Cardiac Catheterization Laboratory and Director of Clinical Electrophysiology. He is a fellow in multiple professional societies and serves on the editorial board as a reviewer for numerous peer review journals. Dr. Moses completed medical school at the University of Pennsylvania School of Medicine and his internship, residency and fellowship in Cardiology at the Presbyterian University of Pennsylvania Medical Center.
Hospital Affiliations
- NewYork-Presbyterian/Columbia
Gender
- Male
Schedule an Appointment
Phone Appointments
Location(s)
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- NYP Employee Plan
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs Plan
Amida Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- Blue Access (Exchange)
- EPO
- Gatekeeper (Exchange)
- HMO
- Medicare Managed Care
- Pathway (Exchange)
- POS
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Medicare
- Traditional Medicare (NY)
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
- Medicare Managed Care
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
Credentials & Experience
Education & Training
- University of Pennsylvania School of Medicine
- Residency: University of Pennsylvania Medical Center
- Fellowship: University of Pennsylvania Medical Center
Board Certifications
- Interventional Cardiology
- Cardiovascular Disease
- Internal Medicine
Honors & Awards
Research Fellowship Award, Southern Pennsylvania Heart Assoc. 1978-1980
Member, PTCA Subcommittee NHLBI-Study of Thrombolysis in
Acute Myocardial Infarction (TIMI) 1986-1987
Consultant: FDA Committee on Biologics 1986
Chairman: New York Angioplasty Society 1987-1988
Lectureship, Sendai Medical College, Tohoku Medical Society,
Sendai, Japan 1990
Lectureship, The Vivian & Norman Weiden Lecture: Innovative
Approaches to Coronary Artery Disease 1996
New York Cardiological Society, NYC
Listed in Best Doctors of the Year, New York Magazine 2004-2016
America’s Top Doctors –Castle Connolly 2005-2016
Lifetime Achievement Award, Cardiovascular Research Foundation 2006
C3 Lifetime Career Achievement Award-C3 Hall of Fame 2010
Research
Grants
PROSPECTIVE, MULTICENTER, SINGLE-ARM, GLOBAL IDE STUDY OF THE SHOCKWAVE CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER IN CALCIFIED CORONARY ARTERIES (DISRUPT CAD III STUDY) (P&S Industry Clinical Trial)
Mar 15 2019 - Mar 15 2024
A PROSPECTIVE MULTICENTER SINGLE ARM TRIAL TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE SYNERGYTM 48 MM EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM (SYNERGYTM STENT SYSTEM) FOR THE TREATMENT OF SUBJECTS WITH ATHEROSCLEROTIC LESION(S) (P&S Industry Clinical Trial)
Jun 13 2018 - Jun 13 2023
CORONARY ORBITAL ATHERECTOMY SYSTEM STUDY (COAST) (P&S Industry Clinical Trial)
Jul 29 2014 - Jul 29 2019
OPEN CTO - OUTCOMES, PATIENT HEALTH STATUS, AND EFFICIENCY IN CHRONIC TOTAL OCCLUSION HYBRID PROCEDURES (P&S Industry Clinical Trial)
Jul 11 2014 - Jul 11 2019
NEUROLOGICAL COMPLICATIONS OF CONTEMPORARY UNPROTECTED TAVR (NEURO TAVR) (P&S Industry Clinical Trial)
Sep 17 2013 - Sep 17 2018
ABSORB RANDOMIZED CONTROLLED TRIAL. A CLINICAL EVALUATION OF ABSORBS BVS, THE EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF SUBJECTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS (P&S Industry Clinical Trial)
Apr 23 2013 - Apr 23 2018
EXCEL STUDY (P&S Industry Clinical Trial)
May 1 2012 - May 1 2017
RESOLUTE US-EVALUATION OF ENDEAVOR RESOLUTE STENT IN CORONARY ARTERIES (P&S Industry Clinical Trial)
Dec 1 2008 - Jun 30 2016
P-0020 (P&S Industry Clinical Trial)
Jun 24 2011 - Jun 24 2016
DUAL ANTI-PLATELET THERAPY (DAPT) IN SUBJECTS UNDERGOING PCI WITH CYPHER STENT (P&S Industry Clinical Trial)
Mar 9 2010 - Mar 9 2015
PLATINUM TRIAL:A PROSPECTIVE,RANDOMIZED,MULTICENTER TRIAL TO ASSESS AN EVEROLIMUS-ELUTING CORONARY STENT SYSTEM(PROMUS) (P&S Industry Clinical Trial)
Mar 1 2009 - Mar 1 2015
A RANDOMIZED STUDY COMPARING THE CLINICAL UTILITY OF THE STEREOTAXIS NAVIGANT COMPUTED TOMOGRAPHY ANGIOGRAPHY IMPORTATIO (P&S Industry Clinical Trial)
Sep 14 2009 - Sep 14 2014
REVIVAL:RANDOMINIZATION OF ENDOVASCULAR IMPLANTATION OF VALVES TRIAL (P&S Industry Clinical Trial)
Jun 1 2005 - Dec 1 2013
MEDTRONIC -- IP057 (P&S Industry Clinical Trial)
Jun 10 2008 - Oct 31 2013
BOSTON SCI--S2037-PI (P&S Industry Clinical Trial)
Jan 28 2008 - Aug 31 2013
BOSTON SCI--S2043-PI (P&S Industry Clinical Trial)
Jan 28 2008 - Aug 31 2013
TRIAL OF THE MEDTRONIC ENDEAVOR DRUG ELUTING STENT VS. THE TAXUS PACLITAXEL ELUTING CORONARY STENT IN DE NOVO NATIVE (P&S Industry Clinical Trial)
May 12 2005 - Nov 30 2012
ANGIOSCORE--ASCST121 (P&S Industry Clinical Trial)
Jun 20 2008 - Jun 30 2011
TOPSPIN: EVALUATION OF THE SAFETY OF THE TOPSPIN INTRAVASCULAR MAGNETIC RESONANCE IMAGING SYSTEM DURING ENDOVASCULAR (P&S Industry Clinical Trial)
Oct 3 2006 - May 31 2009